The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TQB2450 plus anlotinib combined with paclitaxel and cisplatin as first-line treatment of advanced esophageal squamous cell carcinoma (ESCC): Update results of a single-arm, multicenter phase Ⅱ trial.
 
Junsheng Wang
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Yanzhen Guo
No Relationships to Disclose
 
Yufeng Cheng
No Relationships to Disclose
 
Baosheng Li
No Relationships to Disclose
 
Su-xia Luo
Consulting or Advisory Role - KYM Biosciences